The Bangladesh MINIMat and Nepal Janakpur trials measured blood pressure, while the Nepal Sarlahi trial investigated metabolic syndrome (blood pressure, HbA1c, urine microalbumin:creatinine, cholesterol, glucose, insulin, homeostasis model assessment of insulin resistance). Here, INS is linked to metabolic syndrome.